Dual therapy based on raltegravir and nevirapine has been recently proposed as a possible switching strategy in selected patients, due to attractive tolerability and safety profile. We recently reported the pharmacokinetic compatibility of these drugs when administered twice-daily, but data on efficacy and safety of this combination in the clinical setting are scarce.
Efficacy and safety of Nevirapine plus raltegravir as dual regimen in the clinical setting / C., M., A., C., A., C., Guaraldi, G., G., C., L., C., M., L., L., M., M. C., T., L., T., G., D.P., S., B.. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - STAMPA. - 36 (suppl 1):(2013), pp. 15-15. (Italian Conference on AIDS and Retrovirus Torino 12-14 May 2013).
Efficacy and safety of Nevirapine plus raltegravir as dual regimen in the clinical setting
GUARALDI, Giovanni;
2013
Abstract
Dual therapy based on raltegravir and nevirapine has been recently proposed as a possible switching strategy in selected patients, due to attractive tolerability and safety profile. We recently reported the pharmacokinetic compatibility of these drugs when administered twice-daily, but data on efficacy and safety of this combination in the clinical setting are scarce.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
